课题基金 / 基金详情

Core D: University of Kentucky Alzheimer's Disease Core Center

Core D: University of Kentucky Alzheimer's Disease Core Center
核心 D:肯塔基大学阿尔茨海默病核心中心
批准号:
10662352
负责人:
PETER T. NELSON
金额:
$28.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-06-30
关键词:
AddressAgingAlzheimer&aposs DiseaseAlzheimer&aposs Disease Core CenterAreaAutopsyBiologicalBiological MarkersBiological Specimen BanksBiometryBrainBrain DiseasesBrain imagingBrain regionCaringCatalogsCerebrospinal FluidCerebrovascular DisordersCerebrumClinicalClinical TrialsCognitiveCollaborationsComplementConsensusCorrelation StudiesCorrelative StudyDNADataDatabasesDementiaDementia with Lewy BodiesDepositionDiagnosisDiagnosticDiseaseDown SyndromeEducationElderlyEnsureEtiologyEvaluationFreezingFrontotemporal Lobar DegenerationsGeneticGenetic studyGenomicsGoalsImpaired cognitionIndividualInfrastructureInvestigationKentuckyLaboratory ResearchLesionMemoryMethodologyMethodsMissionNerve DegenerationNeurofibrillary TanglesOxidative StressPathologicPathologyPatientsPlasmaPreventive measureProcessProtocols documentationPublishingResearchResearch PersonnelResearch SupportResourcesRunningSamplingSenile PlaquesSerumServicesSpecimenStagingStandardizationSyndromeSystemTauopathiesTherapeuticThinnessTissue BanksTissue SampleTissuesUniversitiesWorkage relatedage related neurodegenerationaging brainalpha synucleinblood productbrain tissuecerebrovascular pathologyclinical centercohortdata managementdementeddigitaldigital pathologyexperiencegenome wide association studyhippocampal sclerosisinnovationlimbic-predominant age-related TDP-43 encephalopathymeetingsmixed dementianeuroinflammationneuropathologynovelpre-clinicalprotein TDP-43religious order studystatisticssymposiumsynucleinopathytau Proteinstool

项目摘要

项目成果

PETER T. NELSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Neuropathology Core The overall objective of the Neuropathology Core of the UK-ADRC is to support research on normal brain aging, presymptomatic AD, MCI, early and late AD, mixed dementia syndromes, and other dementing disorders. Autopsies will be performed by our Rapid Autopsy Team on longitudinally followed subjects from our Clinical Core. We will perform short post-mortem interval autopsies, and we will maintain a high autopsy rate. This Core is optimally tailored to help address important research questions. The Core will provide brain tissue, CSF and other biospecimens for investigators at UK, other ADRCs, and outside investigators. The Core will also provide consensus conference determined diagnoses, quantitation of neurofibrillary tangles, neuritic plaques, and diffuse plaques from 8 brain regions, Ab quantitation, Braak staging, CERAD, and NIA-Reagan Institute staging on all autopsied cases, along with evaluation of alpha-synuclein and TDP-43 proteinopathy. This brain bank has been operating continuously for over three decades with a strong track record, so special care will be taken to ensure diagnostic excellence, consistency, and continuity. The Core will maintain a tissue bank of the above specimens and frozen serum, plasma, buffy coats and CSF from living patients. Special emphasis will be placed on generating rigorous quantititative pathologic metrics from digital pathology, and providing investigators with specimens from cognitively intact control subjects with no Ab deposition and sparse tau pathology (successful cerebral aging) and many cases with mixed pathologies. Providing these samples will contribute to clinical-pathological correlation studies and cutting-edge research that include sponsored studies related to AD genomics, oxidative stress, hippocampal sclerosis/LATE, dementia with Lewy bodies, Down syndrome, and neuroinflammation. Frequent consensus conferences will be held with the Clinical, Biomarker, and Data Management and Statistics Cores to help define clinical-pathological diagnoses on all autopsied subjects. The Neuropathology Core is strongly integrated with other Cores of the UK-ADRC, and exploits unique opportunities to conduct clinical-pathological correlative studies on longitudinally followed subjects. Through these methods we will better understand normal brain aging and the transition to multi- etiology dementia with the goal of contributing to therapeutic or preventive measures. The Neuropathology Core complements the other Cores of the UK-ADRC to provide extremely essential diagnoses and tissue samples that are required for many cutting-edge researchers at the University of Kentucky and elsewhere. We will build on our track record of excellence using innovative tools related to brain autopsies, neuropathological diagnoses, tissue banking, and clinical-pathological correlation. Our specific aims are: Aim 1: Provide state-of-the-art neuropathological and biospecimen repository services Aim 2: Leverage neuropathology resources and expertise to contribute to research efforts Aim 3: Integrate with other cores to contribute to administrative, research and educational missions
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core D: University of Kentucky Alzheimer's Disease Core Center
  • 批准号:
    10459469
  • 项目类别:
  • 资助金额:
    $28.01万
  • 财政年份:
    2021
  • 负责人:
    PETER T. NELSON
  • 依托单位:
Core D: University of Kentucky Alzheimer's Disease Core Center
  • 批准号:
    10261965
  • 项目类别:
  • 资助金额:
    $28.57万
  • 财政年份:
    2021
  • 负责人:
    PETER T. NELSON
  • 依托单位:
Novel misfolded proteins in ADRD: proteomics, genetics, and clinical-pathological correlations
  • 批准号:
    9905466
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2019
  • 负责人:
    PETER T. NELSON
  • 依托单位:
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimic
  • 批准号:
    9912063
  • 项目类别:
  • 资助金额:
    $43.41万
  • 财政年份:
    2017
  • 负责人:
    PETER T. NELSON
  • 依托单位:
海外基金